173 related articles for article (PubMed ID: 28978124)
41. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics.
Airley RE; Mobasheri A
Chemotherapy; 2007; 53(4):233-56. PubMed ID: 17595539
[TBL] [Abstract][Full Text] [Related]
42. [Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma].
Chang XJ; Wang CP; Qu JH; Lu YY; Chen Y; Bai WL; Gao XD; Hao LY; Xu GL; Wang H; Yang YP
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):748-52. PubMed ID: 23291068
[TBL] [Abstract][Full Text] [Related]
43. Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET.
Sabet A; Ahmadzadehfar H; Bruhman J; Sabet A; Meyer C; Wasmuth JC; Pieper CC; Biersack HJ; Ezziddin S
Nuklearmedizin; 2014; 53(2):39-45. PubMed ID: 24777354
[TBL] [Abstract][Full Text] [Related]
44. Understanding the Role of GLUT2 in Dysglycemia Associated with Fanconi-Bickel Syndrome.
Sharari S; Kabeer B; Mohammed I; Haris B; Pavlovski I; Hawari I; Bhat AA; Toufiq M; Tomei S; Mathew R; Syed N; Nisar S; Maacha S; Grivel JC; Chaussabel D; Ericsson J; Hussain K
Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140215
[TBL] [Abstract][Full Text] [Related]
45. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094
[TBL] [Abstract][Full Text] [Related]
46. Effect of cell microenvironment on the drug sensitivity of hepatocellular cancer cells.
Bhattacharya B; Huang DQ; Low SHH; Tan GH; Han MJ; Singh S; Tang B; Chang SC; Lim JSY; Omar MFM; Dan YY; Soong R
Oncotarget; 2021 Mar; 12(7):674-685. PubMed ID: 33868588
[TBL] [Abstract][Full Text] [Related]
47. Erratum to: Fanconi-Bickel Syndrome - Mutation in SLC2A2 Gene.
Kehar M; Bijarnia S; Ellard S; Houghton J; Saxena R; Verma IC; Wadhwa N
Indian J Pediatr; 2016 Nov; 83(11):1362. PubMed ID: 27477478
[No Abstract] [Full Text] [Related]
48. Gene network inherent in genomic big data improves the accuracy of prognostic prediction for cancer patients.
Kim YH; Jeong DC; Pak K; Goh TS; Lee CS; Han ME; Kim JY; Liangwen L; Kim CD; Jang JY; Cha W; Oh SO
Oncotarget; 2017 Sep; 8(44):77515-77526. PubMed ID: 29100405
[TBL] [Abstract][Full Text] [Related]
49. Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer-effects of hypoxia.
Hamann I; Krys D; Glubrecht D; Bouvet V; Marshall A; Vos L; Mackey JR; Wuest M; Wuest F
FASEB J; 2018 Sep; 32(9):5104-5118. PubMed ID: 29913554
[TBL] [Abstract][Full Text] [Related]
50. Glucose transporters in cancer - from tumor cells to the tumor microenvironment.
Ancey PB; Contat C; Meylan E
FEBS J; 2018 Aug; 285(16):2926-2943. PubMed ID: 29893496
[TBL] [Abstract][Full Text] [Related]
51. Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function.
Piñeiro Fernández J; Luddy KA; Harmon C; O'Farrelly C
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450598
[TBL] [Abstract][Full Text] [Related]
52. Pan-cancer analysis of SLC2A family genes as prognostic biomarkers and therapeutic targets.
Liu Y; Li X; Yang J; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
Heliyon; 2024 Apr; 10(8):e29655. PubMed ID: 38655365
[TBL] [Abstract][Full Text] [Related]
53. Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers.
Bharadwaj R; Jaiswal S; Velarde de la Cruz EE; Thakare RP
Diseases; 2024 Mar; 12(3):. PubMed ID: 38534987
[TBL] [Abstract][Full Text] [Related]
54. SPP2 plays a role in the tumorigenesis of hepatocellular carcinoma: A bioinformatic based analysis.
Peng H; Liu Y; Song Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1779-1792. PubMed ID: 38448371
[TBL] [Abstract][Full Text] [Related]
55. Metabolic reprogramming in the tumor microenvironment of liver cancer.
Lin J; Rao D; Zhang M; Gao Q
J Hematol Oncol; 2024 Jan; 17(1):6. PubMed ID: 38297372
[TBL] [Abstract][Full Text] [Related]
56. Prediction and verification of the prognostic biomarker
Zhang W; Zhou D; Song S; Hong X; Xu Y; Wu Y; Li S; Zeng S; Huang Y; Chen X; Liang Y; Guo S; Pan H; Li H
Oncol Lett; 2024 Feb; 27(2):70. PubMed ID: 38192676
[TBL] [Abstract][Full Text] [Related]
57. Association between glycolysis markers and prognosis of liver cancer: a systematic review and meta-analysis.
Wang B; Pu R
World J Surg Oncol; 2023 Dec; 21(1):390. PubMed ID: 38114977
[TBL] [Abstract][Full Text] [Related]
58. PTEN-related risk classification models for predicting prognosis and immunotherapy response of hepatocellular carcinoma.
Cao L; Ma X; Zhang J; Yang C; Rong P; Wang W
Discov Oncol; 2023 Jul; 14(1):134. PubMed ID: 37470852
[TBL] [Abstract][Full Text] [Related]
59. Discrimination of GLUTs by Fructose Isomers Enables Simultaneous Screening of GLUT5 and GLUT2 Activity in Live Cells.
Gora N; Weselinski LJ; Begoyan VV; Cooper A; Choe JY; Tanasova M
ACS Chem Biol; 2023 May; 18(5):1089-1100. PubMed ID: 37116192
[TBL] [Abstract][Full Text] [Related]
60. The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy.
Puris E; Fricker G; Gynther M
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
